Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a tiny leg patch replace bulky boots to stop deadly clots in the ICU?

NCT ID NCT05208216

Prevention Sponsor: Manchester University NHS Foundation Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a small, wearable device called geko can help prevent dangerous blood clots in the legs of critically ill adults. The geko device uses mild electrical pulses to stimulate leg muscles, improving blood flow. Researchers compared it to standard compression boots (IPCs) in 40 ICU patients to see if it was practical to use. The goal was to find a simpler, potentially more effective way to protect very sick patients from blood clots.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Nov 2022

Finished

May 2024

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female aged ≥ 18 years. * Intact healthy skin at the proposed site of gekoTM device application. * Within 24 hours of their admission to critical care * Expected to remain in critical care until the day after tomorrow Exclusion Criteria: * Use of any concurrent neuro-modulation drug or device (e.g. neuromuscular blocking agents). * Trauma to the lower limbs that would prevent geko™ from stimulating the common peroneal nerve. * Inability to palpate the fibula head in order to apply geko device effectively * Inability to obtain valid written consent from the participant or their designated legal representative

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute illness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute disease Critical Illness infectious disease with sepsis Sepsis venous thromboembolism prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute illness Critical illness Sepsis Venous thromboembolism

Contacts and locations

Locations

  • Manchester Royal Infirmary

    Manchester, M13 9WL, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.